Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin to Prevent Cardiac Dysfunction in Preeclampsia

NCT04479072 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT04479072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04479072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin to Prevent Cardiac Dysfunction in Preeclampsia
Lead sponsor
University of Chicago
Phase
Phase 4
Overall status
Recruiting
Start date
February 15, 2021
Completion date
December 31, 2026
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia postpartum